-
Invitation Only
This session follows data across the value chain, from practice and farm back into discovery and development, and from developers out to the front line.
-
Open Registration
This session looks at how groups judge new products and protocols, what evidence wins approval, and why promising innovations stall between sign-off and the consulting room.
-
Invitation Only
Reserved for Partner
-
Invitation Only
Reserved for Partner
-
Open Registration
This session sets out the funding routes open to researchers and early founders, what each type of funder looks for, and the deal terms that speed things up or slow them down.
-
Open Registration
This session sets out what contextualised care means in practice, where it opens new markets, and what innovators need to build for it.
-
Invitation Only
Reserved for Partner
-
Invitation Only
Reserved for Partner
-
Open Registration
This session gives researchers and early founders a practical way to test whether an idea can go commercial, what industry partners need to see before they engage, and what to do if the answer is "not yet".
-
Invitation Only
Reserved for Partner
-
Invitation Only
Reserved for Partner
-
Open Registration
Affordability is often the headline, but it can hide a broader question: what does the pet owner actually value? This workshop looks at how the owner experience is being redesigned across the practice journey and in the products themselves.
-
Meeting 1: 1:00pm - 1:20pm
Meeting 2: 1:25pm - 1:45pm
Meeting 3: 1:50pm - 2:10pm
Meeting 4: 2:15pm - 2:35pm
Meeting 5: 2:40pm - 3:00pm -
Founder-led case studies, 20 minutes each, every one focused on a single commercialisation milestone. From seed to Series B, across species and disease areas. Watch live or on demand after the event (attendees only).
-
Our Finalist Founders will provide a 5 minute pitch to our main stage audience of strategic partners, investors and fellow founders, with 2 minutes for live Q&A from the judges panel across the following categories:
3:45pm - 4:10pm: Discovery
4:10pm - 4:35pm: Biopharma
4:35pm - 5:00pm: Diagnostics
-
Our Finalist Founders will provide a 5 minute pitch to our main stage audience of strategic partners, investors and fellow founders, with 2 minutes for live Q&A from the judges panel across the following categories:
5:10pm - 5:35pm: Nutrition
5:35pm - 6:00pm: Technology
-
A welcome to the 12th annual AHNTI, and a first look at the conversations shaping animal health, from Discovery and Development through to the Delivery of Care.
-
Animal health has never had a stronger pipeline of science, products and technology. The next decade of growth depends on how quickly that innovation reaches animals, which means regulators, industry and the people delivering care working together. This opening panel brings those voices together on what it will take to turn today's momentum into lasting growth, in practice and on farm.
-
-
Founder-led case studies, 20 minutes each, every one focused on a single commercialisation milestone. From seed to Series B, across species and disease areas. Watch live or on demand after the event (attendees only).
-
-
Founder-led case studies, 20 minutes each, every one focused on a single commercialisation milestone. From seed to Series B, across species and disease areas. Watch live or on demand after the event (attendees only).
-
-
Founder-led case studies, 20 minutes each, every one focused on a single commercialisation milestone. From seed to Series B, across species and disease areas. Watch live or on demand after the event (attendees only).
-
The most successful innovations start with market analysis around unmet needs. This session explores the value in this approach, starting from what vets and pet parents are actually asking for, and works backwards to the platforms, from VLPs and mAbs through to AI-driven discovery, that could genuinely close that gap.
-
Europe's universities hold some of the most promising early-stage animal health science. Founders, tech transfer teams and corporate scouts share how to turn that science into a company, and how to be ready for the first partner conversation.
-
From microbiome solutions and next-generation vaccines to diagnostics and precision tools, livestock health innovation has never been richer. Far less of it earns a permanent place on farm. This session looks at what the innovations winning real, paid adoption have in common, and how to move from promising trial to routine use.
-
Regulatory approval opens the door; real-world evidence builds confidence in practice. Regulators need clean, tightly controlled study data, while vets and owners make decisions in far more complex conditions. This session looks at how companies bridge that gap after launch and build the trust that drives uptake.
-
Taking a validated product to scale means protecting IP, securing funding and finding the right manufacturing partner, all at once. Told from both sides of one partnership, this session offers a practical playbook for making that move to volume.
-
Herd health programmes are often budgeted as a cost, competing with feed and labour. This session reframes them as a return, showing how diagnostics and data-led nutrition deliver measurable gains in yield, fertility and treatment savings, and how to win producer budget for them.
-
Practices have more data than ever from diagnostics, telehealth, client apps and practice management systems. This session looks at how practices and corporate groups turn that data into better decisions, improving COGS, revenue, staff retention, health outcomes and the owner experience.
-
Monoclonal antibodies, AI diagnostics and cell and gene therapy have all crossed from human medicine into animal health. This session looks at which proven human health science has the strongest case to follow, and how to bring it across first.
-
Antimicrobial resistance, parasiticide resistance and growing environmental expectations are changing which livestock medicines and technologies make it to market. This session puts the regulator's perspective centre stage, looking at where livestock medicines...
-
Pets are living longer, with more chronic conditions such as arthritis, kidney disease and cancer, and owners expect a consumer-grade experience. This session explores the innovations and care models helping practices meet that demand and widen access to care.
-
Meeting 9: 3:40pm - 4:00pm
Meeting 10: 4:05pm - 4:25pm
Meeting 11: 4:30pm - 4:50pm
Meeting 12: 4:55pm - 5:15pm
Meeting 13: 5:20pm - 5:40pm
Meeting 14: 5:45pm - 6:05pm
Meeting 15: 6:10pm - 6:30pm -
Founder-led case studies, 20 minutes each, every one focused on a single commercialisation milestone. From seed to Series B, across species and disease areas. Watch live or on demand after the event (attendees only).
-
Meeting 16: 8:10am - 8:30am
Meeting 17: 8:35am - 8:55am
-
New
The business case for healthier cattle is strong on paper, environmentally and economically, but on farm economics still make new technology a hard sell.
-
New
Dog health innovation is maturing fast, but Europe's insurance and vet access patterns look nothing like the US market it's often built for.
-
New
African Swine Fever keeps proving that biosecurity is the difference between a healthy herd and a wiped out one, but investment still lags the risk.
-
New
Equine health innovation struggles to attract investment because the market doesn't fit neatly into either companion or livestock economics.
-
New
Cats are still treated like small dogs in research and product design, even though owners manage their care completely differently.
-
New
Avian flu keeps forcing tough decisions on farm, but the tools to prevent it are still catching up to the risk.
-
New
New treatments for chronic itch are arriving quickly, but turning that science into confident, everyday care is taking longer.
-
New
The pressure to cut antibiotic use keeps growing, but the alternatives aren't yet cheap, proven or accessible enough to replace it.
Speaker(s) -
NewNew treatments for chronic pain arrive faster than vets and owners can build trust in them.
Read More -
New
New tests can catch cancer earlier than ever, but there aren't enough specialists or affordable options to act on what they find.
-
New
Microbiome science is moving from correlation to real treatment, but most products on the shelf are still ahead of the evidence.
-
New
The science of ageing is moving fast, but "longevity" still means something different to a scientist, a vet and an owner.
-
Meeting 18: 10:00am - 10:20am
Meeting 19: 10:25am - 10:45am
Meeting 20: 10:55am - 11:15am
-
Partnerships in animal health are proliferating, but not every deal delivers what either side hoped for.
-
Meeting 21: 2:00pm - 2:20pm
Meeting 22: 2:25pm - 2:45pm
Meeting 23: 2:50pm - 3:10pm
Meeting 24: 3:15pm - 3:35pm
Meeting 25: 3:40pm - 4:00pm
Meeting 26: 4:05pm - 4:25pm
Meeting 27: 4:30pm - 4:50pm